Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
Pedreño M, Sepúlveda M, Armangué T, Sabater L, Martínez-Hernandez E, Arrambide G, Blanco Y, Llufriu S, Martínez-Lapiscina EH, Mulero P, Sola-Valls N, Ruiz-García R, Tintoré M, Dalmau J, Graus F, Saiz A. Pedreño M, et al. Among authors: arrambide g. Mult Scler Relat Disord. 2019 Feb;28:230-234. doi: 10.1016/j.msard.2019.01.007. Epub 2019 Jan 3. Mult Scler Relat Disord. 2019. PMID: 30623863
Early onset multiple sclerosis: the role of gender.
Tintoré M, Arrambide G. Tintoré M, et al. Among authors: arrambide g. J Neurol Sci. 2009 Nov 15;286(1-2):31-4. doi: 10.1016/j.jns.2009.07.016. Epub 2009 Aug 15. J Neurol Sci. 2009. PMID: 19683727
Value of NMO-IgG determination at the time of presentation as CIS.
Costa C, Arrambide G, Tintore M, Castilló J, Sastre-Garriga J, Tur C, Río J, Saiz A, Vidal-Jordana A, Auger C, Nos C, Rovira A, Comabella M, Horga A, Montalban X. Costa C, et al. Among authors: arrambide g. Neurology. 2012 May 15;78(20):1608-11. doi: 10.1212/WNL.0b013e3182563b32. Epub 2012 May 2. Neurology. 2012. PMID: 22551725
Clinical impact of early brain atrophy in clinically isolated syndromes.
Pérez-Miralles F, Sastre-Garriga J, Tintoré M, Arrambide G, Nos C, Perkal H, Río J, Edo MC, Horga A, Castilló J, Auger C, Huerga E, Rovira A, Montalban X. Pérez-Miralles F, et al. Among authors: arrambide g. Mult Scler. 2013 Dec;19(14):1878-86. doi: 10.1177/1352458513488231. Epub 2013 May 7. Mult Scler. 2013. PMID: 23652215
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X. Tur C, et al. Among authors: arrambide g. PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013. PLoS One. 2013. PMID: 24340060 Free PMC article. Clinical Trial.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Höftberger R, Sepulveda M, Armangue T, Blanco Y, Rostásy K, Calvo AC, Olascoaga J, Ramió-Torrentà L, Reindl M, Benito-León J, Casanova B, Arrambide G, Sabater L, Graus F, Dalmau J, Saiz A. Höftberger R, et al. Among authors: arrambide g. Mult Scler. 2015 Jun;21(7):866-874. doi: 10.1177/1352458514555785. Epub 2014 Oct 24. Mult Scler. 2015. PMID: 25344373 Free PMC article.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Vidal-Jordana A, Tintoré M, Tur C, Pérez-Miralles F, Auger C, Río J, Nos C, Arrambide G, Comabella M, Galán I, Castilló J, Sastre-Garriga J, Rovira A, Montalban X. Vidal-Jordana A, et al. Among authors: arrambide g. Mult Scler. 2015 May;21(6):780-5. doi: 10.1177/1352458514549401. Epub 2014 Nov 12. Mult Scler. 2015. PMID: 25392320
99 results